Jane Street’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-26,572
Closed -$903 – 9700
2023
Q2
$903 Sell
26,572
-1,123
-4% -$49 ﹤0.01% 8555
2023
Q1
$1.92K Sell
27,695
-1,186
-4% -$100 ﹤0.01% 8859
2022
Q4
$725 Sell
28,881
-3,074
-10% -$246 ﹤0.01% 8977
2022
Q3
$7K Buy
31,955
+6,247
+24% +$1.54K ﹤0.01% 9409
2022
Q2
$3K Sell
25,708
-563
-2% -$93 ﹤0.01% 9461
2022
Q1
$11K Sell
26,271
-36
-0.1% -$12 ﹤0.01% 10061
2021
Q4
$11K Sell
26,307
-135
-0.5% -$93 ﹤0.01% 9901
2021
Q3
$17K Buy
26,442
+584
+2% +$561 ﹤0.01% 9765
2021
Q2
$39K Buy
25,858
+704
+3% +$1.15K ﹤0.01% 9552
2021
Q1
$43K Buy
+25,154
New +$51K ﹤0.01% 8868

Other funds holding APGNW

Jane Street's APGNW Position: Q3 2023 in Review

Jane Street sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 26,572 shares — an estimated $903 sold.

Jane Street first reported a position in APGNW in Q1 2021 and held it in 10 quarters. The position peaked at $43K in Q1 2021. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

  • Jane Street reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 26,572 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $903.
  • Jane Street first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 10 quarters.
  • Jane Street's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $43K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.